Pitastin Duo Tablets (Pitavastatin Calcium, Fenofibrate)

Adult dose

As a recommended dose, take 1 tablet once daily immediately after a meal.

This medication carries a risk of muscle problems, so if symptoms such as muscle pain or weakness occur before taking it, you must inform your healthcare provider. Special caution is necessary for the elderly over 65 years, women, individuals with poor kidney function, those with uncontrolled hypothyroidism, and those with a history of muscle disorders or alcoholism. The risk of muscle toxicity may increase when taking this medication with other lipid-lowering agents or certain medications, so consult with your healthcare provider before combination therapy. Individuals with impaired liver function or liver disease should undergo liver function tests prior to taking this medication and continue to have regular liver function tests during use. If severe liver impairments or hepatitis symptoms occur, discontinue use immediately. Patients with moderate to severe kidney impairment should not take this medication, and those with mild kidney impairment should carefully monitor kidney function during use. This medication should not be administered to individuals with pancreatitis or gallbladder disease, and in cases where gallstones are suspected, confirmation through testing should be performed before deciding to take it. Pregnant or potentially pregnant women and breastfeeding women should not use this medication. It has not been confirmed safe or effective for use in children. During treatment with this medication, blood lipid levels should be monitored regularly, and if no effect is observed within 3 months, discontinuation should be considered. If surgery is planned or significant clinical events occur, consider temporary discontinuation. Symptoms such as fatigue, dizziness, headache, dyspepsia, and muscle pain may occur, and if these symptoms are severe or persist, consult with your healthcare provider. It is recommended to take this medication with food, as particularly fenofibrate is better absorbed when taken with food. Caution is needed as dizziness can occur while driving or operating machinery. Inform your healthcare provider if you are taking other medications during treatment, as there may be potential interactions. There are no specific antidotes for overdose, so appropriate treatment should be received according to symptoms, and keep out of reach of children.

Serious side effects

Urticaria, angioedema, severe allergic reactions, severe skin adverse reactions (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), thrombosis (pulmonary embolism, deep vein thrombosis), pancreatitis, jaundice, liver abnormalities, rhabdomyolysis, myopathy, muscle cramps, proximal muscle weakness, immune-mediated necrotizing myopathy, acute renal failure, worsening renal function, interstitial lung disease, sudden and severe headache, paralysis, altered consciousness

Mild side effects

• Nasopharyngitis
• upper respiratory tract infections
• dizziness
• hypertension
• chronic gastritis
• erosive gastritis
• headache
• fatigue
• stiffness
• drowsiness

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. Proper storage will help safely maintain the medication's effectiveness.

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle